Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immune system discovery could aid fight against TB

20.10.2006
A key aspect of how the body kicks the immune system into action against tuberculosis is revealed in research published today. The authors, writing in Science, hope that their research could aid the development of novel vaccines and immunotherapies to combat TB, which is responsible for two million deaths each year.

The cause of TB is a slow-growing bacterium known as Mycobacterium tuberculosis. Scientists have known for some time that when host cells are invaded by this bacterium, the host cells are able to call up additional immune cells such as lymphocytes to fight them and try to limit the damage which the bacteria can cause.

The new research, by scientists from Imperial College London, the Universities of Cambridge and Oxford, and other international institutions, identifies a receptor on the host cells which triggers the immune cells’ response to tuberculosis. The scientists demonstrated that without this receptor, known as CCR5, mycobacteria were able to thrive inside host cells, as the immune cells did not receive the signal from CCR5 to attack them.

The scientists hope that their findings could enable a novel vaccine or immunotherapy to be developed which could artificially kick the immune cells into action in the same way as CCR5. This could boost the immune response to TB.

... more about:
»CCR5 »Tuberculosis »Vaccine »immune cell »receptor

Both types of interventions are urgently required, since the BCG vaccine does not offer optimal protection and the current treatment regimens for tuberculosis require at least 6 months medication. This encourages the development of multi-drug resistant strains, as patients often do not complete the full course of treatment.

Dr Beate Kampmann, from the Wellcome Trust Centre for Clinical Tropical Medicine and the Department of Paediatrics at Imperial College London, and one of the authors of the study, said: “These results describe a novel mechanism whereby Mycobacterium tuberculosis communicates with the human immune system. Another piece of this complex jigsaw has been filled in, which will help us to target TB with very specific drugs or vaccines.

"We can now test potential vaccines or drug candidates for the desired effect, as we understand better how they should act," adds Dr Kampmann.

The scientists believe their research will also be of interest to those developing new drugs to combat HIV, which work by inhibiting the CCR5 receptor, which plays an important role in HIV-infection. The new research suggests that such drugs could impair the ability to fight off TB in HIV-infected patients receiving CCR5 receptor antagonists. TB is a big problem for individuals with HIV, as their weakened immune system renders them highly susceptible to this disease.

This research was funded by the Wellcome Trust, the UK Medical Research Council and the Swiss National Science Foundation. It was carried out by scientists from Imperial College London, UK; the University of Cambridge, UK; the University of Oxford, UK; National University of Singapore; Nanyang Technological University, Singapore; the University of Basel, Switzerland; and Lionex Diagnostics and Therapeutics GmbH, Germany.

Laura Gallagher | alfa
Further information:
http://www.imperial.ac.uk

Further reports about: CCR5 Tuberculosis Vaccine immune cell receptor

More articles from Life Sciences:

nachricht The irresistible fragrance of dying vinegar flies
16.08.2017 | Max-Planck-Institut für chemische Ökologie

nachricht How protein islands form
15.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

Im Focus: Scientists improve forecast of increasing hazard on Ecuadorian volcano

Researchers from the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science, the Italian Space Agency (ASI), and the Instituto Geofisico--Escuela Politecnica Nacional (IGEPN) of Ecuador, showed an increasing volcanic danger on Cotopaxi in Ecuador using a powerful technique known as Interferometric Synthetic Aperture Radar (InSAR).

The Andes region in which Cotopaxi volcano is located is known to contain some of the world's most serious volcanic hazard. A mid- to large-size eruption has...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New thruster design increases efficiency for future spaceflight

16.08.2017 | Physics and Astronomy

Transporting spin: A graphene and boron nitride heterostructure creates large spin signals

16.08.2017 | Materials Sciences

A new method for the 3-D printing of living tissues

16.08.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>